KLOW Blend 80mg
KPV + LL-37 + Oxytocin
CAS: N/A
KLOW Blend combines KPV (anti-inflammatory MC receptor agonist), LL-37 (antimicrobial + angiogenic cathelicidin), and Oxytocin (wound healing + bonding neuropeptide) for multi-mechanism recovery and skin repair research. 98.5% HPLC purity.
Specifications
For laboratory research use only. Not for human consumption.
Mechanism of Action
Triple-pathway blend: KPV suppresses NF-kB/cytokine inflammation at MC1R/MC3R. LL-37 activates FPR2 for immune modulation and VEGF-driven angiogenesis. Oxytocin accelerates wound contraction via OXTR-mediated fibroblast activation.
Research FAQ
What research scenarios suit the KLOW Blend?
KLOW covers three non-overlapping wound/recovery mechanisms simultaneously: KPV for mucosal inflammation, LL-37 for antimicrobial + angiogenesis, oxytocin for wound contraction. Useful when broad tissue repair coverage is the research goal.
